Pharmacological Mechanisms in Alzheimer's Therapeutics
| Autor Corporativo: | |
|---|---|
| Otros Autores: | |
| Formato: | eBook |
| Lenguaje: | English |
| Publicado: |
New York, NY :
Springer New York : Imprint: Springer,
2007.
|
| Edición: | 1st ed. 2007. |
| Materias: | |
| Acceso en línea: | https://doi.org/10.1007/978-0-387-71522-3 |
Tabla de Contenidos:
- Overview of the Alzheimer's Disease Pathology and Potential Therapeutic Targets
- Trial Designs and Outcomes to Monitor Novel Therapeutics in Alzheimer's Disease
- The Pharmacological Treatment of Alzheimer's Disease with Cholinesterase Inhibitors and Memantine
- M1 Muscarinic Agonists: A Comprehensive Therapy Against Major Hallmarks of Alzheimer's Disease
- Cholinergic Neurodegeneration in Alzheimer's Disease: Basis for Nerve Growth Factor Therapy
- The Rationale for Glutamatergic Therapy in Alzheimer's Disease
- Secretases as Pharmacological Targets in Alzheimer's Disease
- ?-Secretase as a Target for Alzheimer's Disease
- The Rationale for an Immunological Approach to Alzheimer's Therapeutics
- Neuroinflammation, Alzheimer Disease, and Other Aging Disorders
- Nonsteroidal Anti-inflammatory Drugs (NSAIDs) and Derived A?42-Lowering Molecules for Treatment and Prevention of Alzheimer's Disease (AD)
- The Potential Application of Antioxidant Agents in Alzheimer Disease Therapeutics
- Apolipoprotein E: A Potent Gene-Based Therapeutic Target for the Treatment of Sporadic Alzheimer's Disease
- Tau Pathology as a Target in Alzheimer's Therapeutics
- Design of Inhibitors of Amyloid-? Misfolding and Aggregation for Alzheimer's Therapy
- Potential Applications of Glycosaminoglycan-Related Compounds in Alzheimer's Disease
- Multifunctional Neuroprotective Drugs for the Treatment of Alzheimer's Disease
- Interpreting Clinical Studies of Putative Therapeutics for Alzheimer's Disease: The Case of Statins and NSAIDs.